Is a complete RNTX research report available?

No complete published report is available for Rein Therapeutics Inc. (RNTX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Rein Therapeutics Inc. (RNTX)

NASDAQ: RNTX · USD

$0.77

+0.01 (+1.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first RNTX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	71.5M
Net income (ttm)	-50.2M
EPS (ttm)	-$1.82
Shares out	93M
Volume	182,103
Beta	1.35
Price target	$6.00	+681.3%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -50.2M
EPS (ttm): -$1.82
Market cap: 71.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All RNTX indicators

Market & fundamental data

Available fields

180

Groups with data

Currency

USD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001420565
Company name	Rein Therapeutics Inc.
Country	United States
Country code	US
Cusip	00887A204
Employees	10
Employees Change	-1%
Employees Change Percent	-9.09
Enterprise value	$71.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US00887A2042
Last refreshed	2026-07-31
Market cap	$71.5M
Market cap category	Micro-Cap
Price	$0.77
Price currency	USD
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2834
Symbol	RNTX
Website	https://www.reintx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-70.46%
FCF yield	-23.31%
P/B ratio	6.15x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-50.2M
Net Income Growth Years	1%
Profit Per Employee	$-5M
ROA	-32.1
Roa5y	-33.59
ROCE	-397.2
ROE	-163.4
Roe5y	-85.98
ROIC	-40.58

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-38.58%
Cagr3y	-24.29%
Cagr5y	-48.31%
EPS Growth Quarters	5
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$26.3M
Cash	$4.4M
Current Assets	$5.5M
Current Liabilities	$13.6M
Debt	$4.9M
Debt Equity	$0.42
Equity	$11.6M
Liabilities	$14.7M
Long Term Assets	$20.8M
Long Term Liabilities	$1.1M
Net Cash	$-478,000
Net Cash By Market Cap	$-0.67
Net Debt Equity	$0.04
Tangible Book Value	$-53.2M
Tangible Book Value Per Share	$-1.9
WACC	10.91

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.4
Net Working Capital	$-7.7M
Quick ratio	0.33
Working Capital	$-8.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-29.11%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-38.56%
200-day SMA	1.24
3Y total return	-56.61%
50-day SMA	0.95
50-day SMA vs 200-day SMA	50under200
5Y total return	-96.31%
All Time High	309.6
All Time High Change	-99.75%
All Time High Date	2017-10-05
All Time Low	0.73
All Time Low Change	4.93%
All Time Low Date	2026-07-28
ATR	0.08
Beta	1.35
Beta1y	1.47
Beta2y	1.25
Ch YTD	-33.79
High	0.83
High52	2.18
High52 Date	2025-11-03
High52ch	-64.77%
Low	0.75
Low52	0.73
Low52 Date	2026-07-28
Low52ch	4.93%
Ma50ch	-18.97%
Premarket Change Percent	1.58
Premarket Price	$0.77
Premarket Volume	3,100
Price vs 200-day SMA	-37.91%
RSI	34.28
RSI Monthly	36.77
RSI Weekly	37.28
Sharpe ratio	-0.13x
Sortino ratio	-0.13
Total Return	-29.11%
Tr YTD	-33.79
Tr1m	-26.15%
Tr1w	-4.01%
Tr3m	-39.76%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	0
Analyst Ratings	Buy
Earnings EPS Estimate	$-0.27
Operating Income	$-21.6M
Price target	$6
Price Target Change	$681

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	72,115,685%
Float Percent	77.51%
Net Borrowing	4,300,000
Shares Insiders	6.16%
Shares Institutions	9.27%
Shares Out	93,039,032
Shares Qo Q	3.72%
Shares Yo Y	29.11%
Short Float	1.22%
Short Ratio	1.5
Short Shares	0.94

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-18.7M
Adjusted OCF	-18,726,000
Average Volume	391,886.6x
Bv Per Share	-1.19
Ch1m	-26.15
Ch1w	-4.01
Ch1y	-38.56
Ch3m	-39.76
Ch3y	-56.61
Ch5y	-96.31
Ch6m	-46.29
Change	1.32%
Change From Open	1.9
Close	0.76
Days Gap	-0.57
Depreciation Amortization	-14,500
Dollar Volume	139,855.1
Earnings Date	2026-08-14
Earnings Time	amc
EBIT	$-50.3M
EBITDA	$-50.3M
EPS	$-1.82
F Score	1
FCF	$-16.6M
FCF EV Yield	-23.15x
FCF Per Share	$-0.18
Financing CF	13,671,000
Fiscal Year End	December
Founded	2,001
Goodwill	6,330,000
Income Tax	$-712,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Date	2022-11-11
Last Split Type	Reverse
Last10k Filing Date	2026-03-26
Ma150	1.18
Ma150ch	-34.8%
Ma20	0.89
Ma20ch	-13.38%
Net CF	-2,983,000
Next Earnings Date	2026-08-13
Open	0.75
Optionable	No
Position In Range	18.82
Post Close	0.77
Postmarket Change Percent	4.99
Postmarket Price	$0.81
Pre Close	0.76
Price Date	2026-07-30
Relative Volume	0.47x
Share Based Comp	2,116,000
Tr6m	-46.29%
Us State	Texas
Volume	182,103

Rein Therapeutics Inc. (RNTX)

Coverage state: Market snapshot only — no published research

Generate the first RNTX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · RNTX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All RNTX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on RNTX

Frequently asked questions